Literature DB >> 16612770

Drug-, toxin-, and radiation therapy-induced eosinophilic pneumonia.

Joshua Solomon1, Marvin Schwarz.   

Abstract

A significant number of drugs and toxins have been associated with eosinophilic pneumonia. Antibiotics and NSAID, are the most commonly reported drugs. Toxins suspected to cause eosinophilic pneumonia include cigarette smoke and illicit drugs. Drug- or toxin-induced eosinophilic pneumonia is indistinguishable from idiopathic acute or chronic eosinophilic pneumonia by clinical, radiographic, and histopathologic criteria. The diagnosis is supported by a temporal relationship to a drug or toxin. The condition usually resolves with removal from the agent and recurs with rechallenge. Treatment involves discontinuation of the offending drug or toxin and treatment with corticosteroids in severe respiratory failure. There are also mass outbreaks of eosinophilic pneumonia reported, such as the toxic-oil syndrome in 1981 and the eosinophilia-myalgia syndrome related to the ingestion of L-tryptophan in 1989. A recent report has described an outbreak of acute eosinophilic pneumonia found in soldiers in Iraq. Radiation therapy has also been associated with the development of eosinophilic pneumonia in patients receiving this treatment for breast cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16612770     DOI: 10.1055/s-2006-939522

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  27 in total

1.  Eosinophilic pneumonia associated with pirfenidone therapy.

Authors:  Diana C Gomez; Borna Mehrad
Journal:  Eur Respir J       Date:  2016-07-07       Impact factor: 16.671

Review 2.  Eosinophilic pneumonia in patients treated with daptomycin: review of the literature and US FDA adverse event reporting system reports.

Authors:  Peter W Kim; Alfred F Sorbello; Ronald T Wassel; Tracy M Pham; Joseph M Tonning; Sumathi Nambiar
Journal:  Drug Saf       Date:  2012-06-01       Impact factor: 5.606

3.  A pneumonia that will not go away.

Authors:  Khaled R Khasawneh; Tashfeen Mahmood; Ruba A Halloush; Faisal A Khasawneh
Journal:  Can Respir J       Date:  2014-02-12       Impact factor: 2.409

4.  Piperacillin-associated pulmonary infiltrates with eosinophilia: a case report.

Authors:  Olivia Ling-I Tseng; John Thomas Kelsall; Pearce George Wilcox
Journal:  Can Respir J       Date:  2010 Mar-Apr       Impact factor: 2.409

5.  A rare cause of pulmonary infiltrates one should be aware of: a case of daptomycin-induced acute eosinophilic pneumonia.

Authors:  C Rether; A Conen; M Grossenbacher; W C Albrich
Journal:  Infection       Date:  2011-06-30       Impact factor: 3.553

Review 6.  Eosinophilic pneumonias.

Authors:  Praveen Akuthota; Peter F Weller
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

7.  Eosinophilic pneumonia associated with bleomycin in a patient with mediastinal seminoma: a case report.

Authors:  Sanjaykumar Hapani; David Chu; Shenhong Wu
Journal:  J Med Case Rep       Date:  2010-04-29

8.  Imipenem/cilastatin-induced acute eosinophilic pneumonia.

Authors:  Kap Sum Foong; Ashley Lee; Marijeta Pekez; Wei Bin
Journal:  BMJ Case Rep       Date:  2016-03-04

9.  PHD inhibition mitigates and protects against radiation-induced gastrointestinal toxicity via HIF2.

Authors:  Cullen M Taniguchi; Yu Rebecca Miao; Anh N Diep; Colleen Wu; Erinn B Rankin; Todd F Atwood; Lei Xing; Amato J Giaccia
Journal:  Sci Transl Med       Date:  2014-05-14       Impact factor: 17.956

10.  Chronic eosinophilic pneumonitis due to the inhalation of aerosolized face lotion: A case report.

Authors:  Masafumi Shimoda; Kozo Morimoto; Yoshiaki Tanaka; Tamiko Takemura; Teruaki Oka; Kozo Yoshimori; Ota Ken
Journal:  Medicine (Baltimore)       Date:  2021-05-14       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.